Literature DB >> 29896896

Technical Note: Extension of CERR for computational radiomics: A comprehensive MATLAB platform for reproducible radiomics research.

Aditya P Apte1, Aditi Iyer1, Mireia Crispin-Ortuzar1,2, Rutu Pandya1, Lisanne V van Dijk1,3, Emiliano Spezi4, Maria Thor1, Hyemin Um1, Harini Veeraraghavan1, Jung Hun Oh1, Amita Shukla-Dave1, Joseph O Deasy1.   

Abstract

PURPOSE: Radiomics is a growing field of image quantitation, but it lacks stable and high-quality software systems. We extended the capabilities of the Computational Environment for Radiological Research (CERR) to create a comprehensive, open-source, MATLAB-based software platform with an emphasis on reproducibility, speed, and clinical integration of radiomics research.
METHOD: The radiomics tools in CERR were designed specifically to quantitate medical images in combination with CERR's core functionalities of radiological data import, transformation, management, image segmentation, and visualization. CERR allows for batch calculation and visualization of radiomics features, and provides a user-friendly data structure for radiomics metadata. All radiomics computations are vectorized for speed. Additionally, a test suite is provided for reconstruction and comparison with radiomics features computed using other software platforms such as the Insight Toolkit (ITK) and PyRadiomics. CERR was evaluated according to the standards defined by the Image Biomarker Standardization Initiative. CERR's radiomics feature calculation was integrated with the clinically used MIM software using its MATLAB® application programming interface.
RESULTS: The CERR provides a comprehensive computational platform for radiomics analysis. Matrix formulations for the compute-intensive Haralick texture resulted in speeds that are superior to the implementation in ITK 4.12. For an image discretized into 32 bins, CERR achieved a speedup of 3.5 times over ITK. The CERR test suite enabled the successful identification of programming errors as well as genuine differences in radiomics definitions and calculations across the software packages tested.
CONCLUSION: The CERR's radiomics capabilities are comprehensive, open-source, and fast, making it an attractive platform for developing and exploring radiomics signatures across institutions. The ability to both choose from a wide variety of radiomics implementations and to integrate with a clinical workflow makes CERR useful for retrospective as well as prospective research analyses.
© 2018 American Association of Physicists in Medicine.

Entities:  

Keywords:  imaging biomarker; inter-software test; machine learning; open source software; radiomics; reproducibility

Year:  2018        PMID: 29896896      PMCID: PMC6597320          DOI: 10.1002/mp.13046

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  14 in total

1.  CERR: a computational environment for radiotherapy research.

Authors:  Joseph O Deasy; Angel I Blanco; Vanessa H Clark
Journal:  Med Phys       Date:  2003-05       Impact factor: 4.071

2.  3D Slicer as an image computing platform for the Quantitative Imaging Network.

Authors:  Andriy Fedorov; Reinhard Beichel; Jayashree Kalpathy-Cramer; Julien Finet; Jean-Christophe Fillion-Robin; Sonia Pujol; Christian Bauer; Dominique Jennings; Fiona Fennessy; Milan Sonka; John Buatti; Stephen Aylward; James V Miller; Steve Pieper; Ron Kikinis
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

3.  Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships.

Authors:  I El Naqa; G Suneja; P E Lindsay; A J Hope; J R Alaly; M Vicic; J D Bradley; A Apte; J O Deasy
Journal:  Phys Med Biol       Date:  2006-10-19       Impact factor: 3.609

4.  MaZda--a software package for image texture analysis.

Authors:  Piotr M Szczypiński; Michał Strzelecki; Andrzej Materka; Artur Klepaczko
Journal:  Comput Methods Programs Biomed       Date:  2008-10-14       Impact factor: 5.428

5.  IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics.

Authors:  Lifei Zhang; David V Fried; Xenia J Fave; Luke A Hunter; Jinzhong Yang; Laurence E Court
Journal:  Med Phys       Date:  2015-03       Impact factor: 4.071

6.  Multiplicative intrinsic component optimization (MICO) for MRI bias field estimation and tissue segmentation.

Authors:  Chunming Li; John C Gore; Christos Davatzikos
Journal:  Magn Reson Imaging       Date:  2014-04-30       Impact factor: 2.546

Review 7.  Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology.

Authors:  E J Limkin; R Sun; L Dercle; E I Zacharaki; C Robert; S Reuzé; A Schernberg; N Paragios; E Deutsch; C Ferté
Journal:  Ann Oncol       Date:  2017-06-01       Impact factor: 32.976

Review 8.  Radiomics: extracting more information from medical images using advanced feature analysis.

Authors:  Philippe Lambin; Emmanuel Rios-Velazquez; Ralph Leijenaar; Sara Carvalho; Ruud G P M van Stiphout; Patrick Granton; Catharina M L Zegers; Robert Gillies; Ronald Boellard; André Dekker; Hugo J W L Aerts
Journal:  Eur J Cancer       Date:  2012-01-16       Impact factor: 9.162

9.  Computational Radiomics System to Decode the Radiographic Phenotype.

Authors:  Joost J M van Griethuysen; Andriy Fedorov; Chintan Parmar; Ahmed Hosny; Nicole Aucoin; Vivek Narayan; Regina G H Beets-Tan; Jean-Christophe Fillion-Robin; Steve Pieper; Hugo J W L Aerts
Journal:  Cancer Res       Date:  2017-11-01       Impact factor: 12.701

10.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.

Authors:  Hugo J W L Aerts; Emmanuel Rios Velazquez; Ralph T H Leijenaar; Chintan Parmar; Patrick Grossmann; Sara Carvalho; Sara Cavalho; Johan Bussink; René Monshouwer; Benjamin Haibe-Kains; Derek Rietveld; Frank Hoebers; Michelle M Rietbergen; C René Leemans; Andre Dekker; John Quackenbush; Robert J Gillies; Philippe Lambin
Journal:  Nat Commun       Date:  2014-06-03       Impact factor: 14.919

View more
  39 in total

1.  Radiomics in nuclear medicine: robustness, reproducibility, standardization, and how to avoid data analysis traps and replication crisis.

Authors:  Alex Zwanenburg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-25       Impact factor: 9.236

Review 2.  NCTN Assessment on Current Applications of Radiomics in Oncology.

Authors:  Ke Nie; Hania Al-Hallaq; X Allen Li; Stanley H Benedict; Jason W Sohn; Jean M Moran; Yong Fan; Mi Huang; Michael V Knopp; Jeff M Michalski; James Monroe; Ceferino Obcemea; Christina I Tsien; Timothy Solberg; Jackie Wu; Ping Xia; Ying Xiao; Issam El Naqa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-01-31       Impact factor: 7.038

3.  Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.

Authors:  Evangelia Katsoulakis; Yao Yu; Aditya P Apte; Jonathan E Leeman; Nora Katabi; Luc Morris; Joseph O Deasy; Timothy A Chan; Nancy Y Lee; Nadeem Riaz; Vaios Hatzoglou; Jung Hun Oh
Journal:  Oral Oncol       Date:  2020-06-30       Impact factor: 5.337

4.  A novel kernel Wasserstein distance on Gaussian measures: An application of identifying dental artifacts in head and neck computed tomography.

Authors:  Jung Hun Oh; Maryam Pouryahya; Aditi Iyer; Aditya P Apte; Joseph O Deasy; Allen Tannenbaum
Journal:  Comput Biol Med       Date:  2020-03-26       Impact factor: 4.589

5.  MRI radiomic features are associated with survival in melanoma brain metastases treated with immune checkpoint inhibitors.

Authors:  Ankush Bhatia; Maxwell Birger; Harini Veeraraghavan; Hyemin Um; Florent Tixier; Anna Sophia McKenney; Marina Cugliari; Annalise Caviasco; Angelica Bialczak; Rachna Malani; Jessica Flynn; Zhigang Zhang; T Jonathan Yang; Bianca D Santomasso; Alexander N Shoushtari; Robert J Young
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

6.  Prediction of lymph node metastases using pre-treatment PET radiomics of the primary tumour in esophageal adenocarcinoma: an external validation study.

Authors:  Chong Zhang; Zhenwei Shi; Petros Kalendralis; Phil Whybra; Craig Parkinson; Maaike Berbee; Emiliano Spezi; Ashley Roberts; Adam Christian; Wyn Lewis; Tom Crosby; Andre Dekker; Leonard Wee; Kieran G Foley
Journal:  Br J Radiol       Date:  2020-12-11       Impact factor: 3.039

7.  Reproducibility analysis of multi-institutional paired expert annotations and radiomic features of the Ivy Glioblastoma Atlas Project (Ivy GAP) dataset.

Authors:  Sarthak Pati; Ruchika Verma; Hamed Akbari; Michel Bilello; Virginia B Hill; Chiharu Sako; Ramon Correa; Niha Beig; Ludovic Venet; Siddhesh Thakur; Prashant Serai; Sung Min Ha; Geri D Blake; Russell Taki Shinohara; Pallavi Tiwari; Spyridon Bakas
Journal:  Med Phys       Date:  2020-12-04       Impact factor: 4.071

8.  Quality control of radiomic features using 3D-printed CT phantoms.

Authors:  Usman Mahmood; Aditya Apte; Christopher Kanan; David D B Bates; Giuseppe Corrias; Lorenzo Manneli; Jung Hun Oh; Yusuf Emre Erdi; John Nguyen; Joseph O'Deasy; Amita Shukla-Dave
Journal:  J Med Imaging (Bellingham)       Date:  2021-06-29

9.  Multiparametric Integrated 18F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding.

Authors:  Lale Umutlu; Julian Kirchner; Nils Martin Bruckmann; Janna Morawitz; Gerald Antoch; Marc Ingenwerth; Ann-Kathrin Bittner; Oliver Hoffmann; Johannes Haubold; Johannes Grueneisen; Harald H Quick; Christoph Rischpler; Ken Herrmann; Peter Gibbs; Katja Pinker-Domenig
Journal:  Cancers (Basel)       Date:  2021-06-11       Impact factor: 6.639

10.  Radiomics and Machine Learning with Multiparametric Breast MRI for Improved Diagnostic Accuracy in Breast Cancer Diagnosis.

Authors:  Isaac Daimiel Naranjo; Peter Gibbs; Jeffrey S Reiner; Roberto Lo Gullo; Caleb Sooknanan; Sunitha B Thakur; Maxine S Jochelson; Varadan Sevilimedu; Elizabeth A Morris; Pascal A T Baltzer; Thomas H Helbich; Katja Pinker
Journal:  Diagnostics (Basel)       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.